Navigation Links
West Announces Second Quarter 2008 Results
Date:8/5/2008

- Reported Diluted EPS of $0.82 Includes Settlement Gain and Restructuring

Costs -

- Adjusted Diluted EPS(1) of $0.73 -

- Maintains Full-Year 2008 Earnings Estimate -

- Conference Call Scheduled for 9 a.m. E.D.T. Today -

LIONVILLE, Pa., Aug. 5 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the second quarter of 2008. Reported diluted earnings per share of $0.82 included net after-tax income of $3.3 million, or $0.09 per diluted share, for the combined effects of a contract settlement gain and restructuring charges.

Summary quarterly results are as follows:

Three Months Ended June 30

($ millions, except per-share data ) 2008 2007

Net Sales $279.3 $263.7

Gross Profit 83.6 76.7

Reported Operating Profit 42.6 34.9

Adjusted Operating Profit (1) 37.4 34.9

Reported Diluted EPS from continuing operations $0.82 $0.74

Adjusted Diluted EPS(1) from continuing operations $0.73 $0.68

(1) See corresponding note under "Supplemental Information and Notes to

Non-GAAP Financial Measures" in the tables following the text of this

release.

Quarterly consolidated revenue increased by 5.9% when compared to the second quarter of 2007, with favorable currency effects and other sales gains outpacing anticipated sales declines for certain products. Currency translati
'/>"/>

SOURCE West Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. CryoCath Announces Fiscal 2008 Third Quarter Results
2. Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results
3. Global Leader In Age Management Announces New Indiana Medical Center
4. ATS Medical Announces Second Quarter Results
5. InteKrin Therapeutics Announces $20 Million Series C Financing
6. HealthFitness Announces 2008 Second Quarter Results
7. USAID Announces New Mission Director to Colombia
8. Navilyst Medical Announces Global Debut Today : Former Boston Scientific Business Units Combine to Lead Fluid Management and Vascular Access Markets
9. Lumension Security Announces General Availability of Sanctuary Endpoint Protection and Data Protection Suite to Safeguard Data and Privacy
10. Split Peas Soup Caf Announces the Opening Of Its El Paso, Texas Location.
11. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... 2014) Population Council scientists and their partners have found ... can prevent the transmission of multiple sexually transmitted infections ... HIV, herpes simplex virus 2 (HSV-2), and human papillomavirus ... that the gel is effective against multiple strains of ... vagina against all three viruses of at least eight ...
(Date:4/17/2014)... A new study has found that India,s shocking rates ... debt-ridden farmers who are clinging to tiny smallholdings ... ,cash crops, such as cotton and coffee, that are ... supports a range of previous case studies that point ... sector following the ,liberalisation, of the nation,s economy during ...
(Date:4/17/2014)... for more research to be carried out into ... Africa. In a paper in The Lancet ... with colleagues in the department of Parasitology and ... Ohio, University of Cambridge and the Royal Veterinary ... burden of HIV/AIDS and schistosomiasis of children, and ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:More research called for into HIV and schistosomiasis coinfection in African children 2
... a new vaccine against childhood pneumonia, meningitis and ear ... Meanwhile, doctors are directing the supplies they do have ... such as those with sickle cell anemia, the AIDS ... ,PREVNAR fights the bacterium streptococcus pneumoniae, the leading ...
... in France, despite a diet rich in butter and other ... red wine, another staple of the French diet. //Scientists say ... explanation is pigments known as polyphenols. ,Polyphenols ... of the arteries. Polyphenols in red wine decreases the amount ...
... to a new study, there is no significant difference ... serotonin reuptake inhibitors (SSRIs) are now very widely used ... a brain chemical called serotonin that plays an important ... how individual SSRIs compare with one another. However, a ...
... A team of UK scientists has found six genes which ... that eventually, doctors will be able to gauge an individual ... genetic makeup.Only a small proportion of breast cancer cases are ... ,Two genes have already been firmly linked with some ...
... a new study alcoholics are prone to a kind of ... the study of alcohol on the health of aged people ... of persistent problem drinking were 20 per cent more likely ... Heavy drinkers ran a 10 per cent greater risk. These ...
... it thins the blood and prevents the clots that ... class of pain relievers known as nonsteroidal anti-inflammatory drugs.// ... and pains. The popular pain reliever ibuprofen blocks the ... sounds a warning for people who take both medicines. ...
Cached Medicine News:
(Date:1/14/2014)... , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new ... targeting guide with accompanying instrumentation to place and insert ... to the soft tissue (e.g. ligament) repair or reconstruction ... repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... , Jan. 14, 2014 NineSigma , ... hold its Innovation Leadership Summit , May 14-16, ... Cleveland Ohio . ... and organizations committed to breakthrough achievements through open innovation. ...
(Date:1/14/2014)... 14, 2014   Evidera , a leading provider of ... Center for Drug Evaluation and Research (CDER), U.S. Food ... guidance document for a patient-reported outcome (PRO) measure in ... Disease Tool [EXACT] for Measurement of Symptoms of Acute ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... N.J., Feb. 1, 2012  Arena Pharmaceuticals, Inc. (NASDAQ: ... the US Food and Drug Administration (FDA) has notified ... meeting to discuss the lorcaserin New Drug Application (NDA) ... 2012. Confirmation and details of the meeting will be ...
... 2012 A new skin cancer drug tested for the ... Virginia G. Piper Cancer Center at Scottsdale Healthcare just received ... remarkable accomplishment in new drug development. (Photo: ... the first time in the world Jan. 23, 2007 in ...
Cached Medicine Technology:Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 2Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 3Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin 4FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen 2FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: